Tekmira Delays Start of Cancer Drug Trial, Sees Expanded Roche Partnership in '09
March 26, 2009
Tekmira Delays Start of Cancer Drug Trial, Sees Expanded Roche Partnership in '09
The company also released its fourth-quarter financial results, posting higher losses on increased research and development spending as it worked to move its first drug into the clinic this year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Alnylam Starts Phase I Study of siRNA Liver Cancer Drug
April 9, 2009 / Gene Silencing News - Strands
February 19, 2009 / Gene Silencing News - Non-targeted siRNAs Curb Blood Vessel Growth
April 29, 2009 / Genome Technology - Calando May 'Scale Back' RNAi Rx Development as Parent Firm Faces Cash Crunch
February 12, 2009 / Gene Silencing News - Traversa Secures $5M in Series B, Nears Close of Research Deals for Delivery Technology
April 2, 2009 / Gene Silencing News